Antimalarial · Artemisinin-based combination therapy
Dihydroartemisinin and piperaquine tablets and dry syrup
A fixed-dose combination for uncomplicated malaria, widely used in Southeast Asia and increasingly in Africa. Progene Pharma supplies dihydroartemisinin and piperaquine as tablets and a dry syrup, under your brand and with the documents you need to register it.
- Forms
- Tablets and dry syrup
- Strengths
- 2 options
- Supply
- Private label or ready brand
- Documents
- COA, COPP, MSDS, dossier
Available strengths
Dihydroartemisinin / piperaquine in each tablet. Strengths for children, and pack sizes by weight band, are made to order. Pack sizes and labelling are made to match your registration.
-
40 / 320 mg
Tablet
-
Dry syrup
Dry syrup
Powder mixed with water, for young children
About dihydroartemisinin and piperaquine
What it treats
Dihydroartemisinin and piperaquine is used to treat uncomplicated malaria caused by Plasmodium falciparum. It is an artemisinin-based combination therapy (ACT), the type of treatment the World Health Organization recommends for this kind of malaria. It is a first-line treatment in several countries, particularly in Southeast Asia, and is used in some malaria programmes beyond treatment.
Why two medicines in one
Dihydroartemisinin acts fast and brings parasite numbers down sharply. Piperaquine is cleared slowly, so it keeps working after the treatment ends and helps protect against new infection for a few weeks. Together they make a three-day course that is simple to take.
How it is taken
Treatment is a short course over three days, once a day, with the dose set by body weight, and it is best taken on an empty stomach rather than with a fatty meal. It is not a treatment for severe malaria, which starts with injectable artesunate. Piperaquine can affect the rhythm of the heart, so it is not suitable for people with heart rhythm problems or those taking certain other medicines. Patients should always follow the approved label in their country.
Prescription medicine. This information is for distributors and healthcare professionals and is not medical advice.
Made for your market
Registration rules differ from country to country. We build the product around yours.
-
Private label
Your brand name on the carton, blister foil and leaflet, designed to your regulator's rules.
-
Packaging
Pack sizes, languages and artwork to suit how the medicine is prescribed and sold in your country.
-
Registration documents
COPP, MSDS and the product dossier for registration, and a COA with every batch.
-
Certified manufacturing
Manufactured in a facility certified to WHO-GMP, EU-GMP and ISO. What each standard means
How ordering works
-
01
Tell us what you need
The strength, pack size, quantity and the country you are registering in.
-
02
Quotation and documents
We confirm price, lead time and the certification and paperwork your regulator expects.
-
03
Manufacture and testing
Manufactured in a certified facility. Every batch is tested and released with a COA.
-
04
Shipping
Packed for export and shipped with the documents you need for import clearance.
Other antimalarials we supply
Ask for any of these with your quotation, or see the full product list.
-
Tablets 20/120 to 80/480 mg; dispersible tablets; dry syrup
-
Injection 60 mg; tablets 50, 100 and 200 mg
-
Tablets in several strengths, including paediatric packs
-
Tablets 500/25 mg
-
Injection 300 mg and 600 mg; tablets
Questions about dihydroartemisinin and piperaquine
Something else? Email [email protected].
Which forms of dihydroartemisinin and piperaquine do you supply?
Tablets of 40 mg / 320 mg and a dry syrup for young children. Other strengths and pack sizes by weight band are made to order, and labelling is made to match the registration in your country.
Is it suitable for children?
Yes, at the dose set for their weight, and the dry syrup is made for young children who cannot swallow tablets. We pack each weight band in the course length your guidelines use.
Why does the label mention the heart?
Piperaquine can affect the rhythm of the heart, so the approved label advises caution for people with heart rhythm problems or who take medicines with the same effect. The label and leaflet we prepare follow the wording your regulator approves.
Can you supply it under our own brand?
Yes. Progene Pharma manufactures it as a private label product, with the carton, blister foil or label and patient leaflet designed for your market and your regulator's requirements.
Which documents come with it?
Every batch ships with a Certificate of Analysis (COA). Progene Pharma also provides the Certificate of Pharmaceutical Product (COPP), MSDS and the product dossier you need to register and import it.
Where is it manufactured?
Progene Pharma manufactures it in a WHO-GMP certified facility in India, also certified to EU-GMP and ISO standards. Tell us your destination country and we will confirm which certification applies to your order.
What is the minimum order quantity and lead time?
Both depend on the strength, pack size and documents your market needs. We confirm them with your quotation, and we work with large importers as well as smaller distributors.
Related pages
- Antimalarials
- Sulfadoxine and pyrimethamine
- Quinine
- Artemether and lumefantrine
- Artesunate
- Private label dihydroartemisinin and piperaquine
- Export documentation
- Dihydroartemisinin and piperaquine export to Africa
- Dihydroartemisinin and piperaquine export to Latin America
- Dihydroartemisinin and piperaquine export to Southeast Asia
- Markets we supply
Request a quote
Send us your product requirements and target country. Our team will reply with a quotation and next steps.
- [email protected]
- Phone
- +91 22 49793146
- +91 90829 70494